Who is sponsoring NCT05799924?

NCT05799924 is sponsored by Honglan Zhu.

What drugs are being tested in NCT05799924?

Interventions in NCT05799924: Transcutaneous electrical acupoint stimulation, non steroidal anti inflammatory drugs.

What condition does NCT05799924 study?

NCT05799924 studies Dysmenorrhea.

Is NCT05799924 still recruiting?

NCT05799924 is currently status unknown. Last updated 5 April 2023.

Last reviewed 2023-04-05 · How we verify

NCT05799924

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Study on the Therapeutic Effect and Mechanism of Transcutaneous Acupoint Electrical Stimulation in Female

Status unknown NA Last updated 5 April 2023

What this trial tests

NA trial testing Transcutaneous electrical acupoint stimulation in Dysmenorrhea in 240 participants. Status unknown.

Timeline

21 February 2023

Primary endpoint
30 December 2023

30 December 2023

Quick facts

Lead sponsor	Honglan Zhu
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	240
Start date	21 February 2023
Primary completion	30 December 2023
Estimated completion	30 December 2023
Sites	1 location across China

Drugs / interventions tested

Transcutaneous electrical acupoint stimulation
non steroidal anti inflammatory drugs

Conditions studied

Dysmenorrhea — all drugs for Dysmenorrhea →

Sponsor

Honglan Zhu

Who can join

Adults 18 to 45, female only, with Dysmenorrhea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to investigate the use of TEAS on female patients with dysmenorrhea. The main questions it aims to answer are: Questions 1：Effect of TEAS on dysmenorrhea Questions 2：Mechanism of TEAS in treatment of dysmenorrhea Participants will wear TEAS devices to treat dysmenorrhea during menstruation The participants in the control group were treated with oral medication for dysmenorrhea

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The prevalence and associated risk factors of primary dysmenorrhea among women in Beijing: a cross-sectional study.
Wang YL, Zhu HL. · · 2025 · cited 4× · PMID 39929936 · DOI 10.1038/s41598-025-89038-5

Verify or expand the search:

Other trials of Transcutaneous electrical acupoint stimulation

Trials testing the same drug.

NCT07133620 — the Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Gastrointestinal Dysfunction After Urologi · NA · not yet recruiting
NCT07117123 — Transcutaneous Electrical Acupoint Stimulation on Postoperative Pharyngeal Pain · NA · not yet recruiting
NCT06772961 — Effect of Percutaneous Electrical Acupoint Stimulation on the Improvement of Incidence of Adverse Respiratory Events · NA · recruiting
NCT06188286 — The Effect of Patient-Controlled TEAS vs Sham TEAS for Improve Quality of Life in Patients With Cancer Pain · NA · not yet recruiting
NCT06718231 — TAES Alleviate Post-VATS Depression · NA · not yet recruiting

Other recruiting trials for Dysmenorrhea

Currently open trials in the same condition.

NCT07209566 — A Research Study Exploring How Musculoskeletal Function and the Autonomic Nervous System Relate to Visceral Pain in Wome · NA · recruiting
NCT07248540 — IV Magnesium in the Treatment of Acute Dysmenorrhea · NA · recruiting
NCT07036913 — Effectiveness of ST With TENS and Stretching Exercises on Menstrual Pain and QOL With Dysmenorrhea. RCT · NA · active not recruiting
NCT07081789 — Music and Puzzle Use in Dysmenorrhea Relief · NA · active not recruiting
NCT06741059 — Effect of TENS on Pain and Symptoms in Primary Dysmenorrhea · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05799924 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Honglan Zhu
Last refreshed: 5 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05799924.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing